Effect of ligands with different affinity on albumin fibril formation

Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin

Human serum albumin (HSA) is the most abundant plasma protein of the circulatory system. It is a multidomain, multifunctional protein that, combining diverse affinities and wide specificity, binds, stores, and transports a variety of biological compounds, pharmacores, and fatty acids. HSA is finding increasing uses in drug-delivery due to its ability to carry functionalized ligands and prodrugs. All this raises the question of competition for binding sites occupancy in case of multiple ligands, which in turn influences the protein structure/dynamic/function relationship and also has an impact on the biomedical applications. In this work, the effects of interactive binding of palmitic acid (PA), warfarin (War) and ibuprofen (Ibu) on the thermal stability of HSA were studied using DSC, ATR-FTIR, and EPR. PA is a high-affinity physiological ligand, while the two drugs are widely used for their anticoagulant (War) and anti-inflammatory (Ibu) efficacy, and are exogenous compounds that accommodate in the deputed drug site DS1 and DS2, respectively overlapping with some of the fatty acid binding sites. The results indicate that HSA acquires the highest thermal stability when it is fully saturated with PA. The binding of this physiological ligand does not hamper the binding of War or Ibu to the native state of the protein. In addition, the three ligands bind simultaneously, suggesting a synergic cooperative influence due to allosteric effects. The increased thermal stability subsequent to binary and multiple ligands binding moderates protein aggregation propensity and restricts protein dynamics. The biophysics findings provide interesting features about protein stability, aggregation, and dynamics in interaction with multiple ligands and are relevant in drug-delivery.

Turn-on fluorescence probing of amyloid fibrils by the proto-berberine alkaloids and the study of their interactions

The aggregation of amyloid proteins is highly related to the occurrence and development of neurodegenerative and metabolic diseases. The detection of amyloid fibrils or monitoring fibrillation process would be necessary to understand the fundamental knowledge about the diseases and further facilitate the research for the drug discovery and disease treatment. In this study, three proto-berberine alkaloids, i.e. berberine, palmatine and coptisine, were examined as three distinctive fluorescent probes to detect amyloid fibrils. These three alkaloids were found to be sensitive to the microenvironment, i.e. viscosity and polarity, with varied fluorescence intensity. They could sensitively probe insulin and lysozyme fibrils with turn-on fluorescence, but did not respond to protein monomers, merited with advantages of larger Stokes shift, greenish-yellow fluorescence and no interference with the fibrillation process. Hydrophobic, electrostatic and hydrogen bond interactions were explored to exist between alkaloids and the fibrils. Moreover, these alkaloids succeeded in monitoring the aggregation process of amyloid proteins in vitro and imaging the fibrils in living cells. The present study demonstrates that the three alkaloids could be the potential candidate fluorescent probes for amyloid fibrils.

Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models

Inhibition of fibril formation is considered a possible treatment strategy for amyloid-related diseases. Understanding the molecular nature of inhibitor action is crucial for the design of drug candidates. In the present review, we describe the common kinetic models of fibril formation and classify known inhibitors by the mechanism of their interactions with the aggregating protein and its oligomers. This mechanism determines the step or steps of the aggregation process that become inhibited and the observed changes in kinetics and equilibrium of fibril formation. The results of numerous studies indicate that possible approaches to antiamyloid inhibitor discovery include the search for the strong binders of protein monomers, cappers blocking the ends of the growing fibril, or the species absorbing on the surface of oligomers preventing nucleation. Strongly binding inhibitors stabilizing the native state can be promising for the structured proteins while designing the drug candidates targeting disordered proteins is challenging.